BlueStar® Genomic Health Care Index
The BlueStar Genomic Health Care Index (BDNA) tracks the performance of the largest and most liquid companies in the global genomic healthcare industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from health care therapies based on targeting or the modification of the genetic makeup of cells or uses mRNA, technology platforms that enable the development of genetics-based health care thearpies, or laboratory equipment or services used to test, code, or develop genetics-based health care companies.
Key Features
| Size and Liquidity Requirements | Float-adjusted market capitalization of at least 300 mln USD. Six-month average-daily-value-traded of at least 200000 USD. |
| Universe | Companies developing or producing gene-based healthcare technologies and therapies. |
| Diversification | Companies are liquidity weighted. |
| Review | Semi-annual in June and December. |
Timescale Slider
| Symbol |
IndexName |
| BDNAPR |
BlueStar® Genomic Health Care Price Index |
| BDNANTR |
BlueStar® Genomic Health Care Total Return Net Index |
